Regional
Southern Fox Valley EMS System
Southern Fox Valley EMS System (IL) carries 31 drugs across 118 dose entries in its current published protocol, effective 2023-04-01.
The current listed document is more than 24 months old and may be outdated.
Drugs and doses31
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 625–1000 mg | PO | not captured | standing | pages 7, 98 |
| Mild to moderate pain | peds | 12.5 mg/kg | PO | not captured | standing | pages 7, 98 |
| Mild to moderate pain | peds | 15 mg/kg | IV | not captured | standing | page 76 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | pages 20, 86, 98 |
| SVT | peds | 0.1 mg/kg (max 6 mg) | IV | not captured | standing | pages 20, 86, 98 |
| Wide-complex tachycardia | adult | 6 mg | IV | not captured | standing | pages 21, 87, 98 |
| Wide-complex tachycardia | peds | 0.1 mg/kg (max 6 mg) | IV | not captured | standing | pages 21, 87, 98 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | not captured | not captured | standing | pages 14, 15, 82, 83 |
| Asthma / bronchospasm | peds | 2.5 mg | not captured | not captured | standing | pages 14, 15, 82, 83 |
| Hyperkalemia | adult | 5 mg | IN/NEB | not captured | standing | pages 26, 56 |
| Hyperkalemia | peds | 5 mg | IN/NEB | not captured | standing | pages 26, 56 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 18, 99 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 19, 85, 99 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 19, 85, 99 |
| Organophosphate poisoning | adult | 1 mg | IV/IO | not captured | standing | pages 30, 90, 99 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 30, 90, 99 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 2.5% gel | TOP | not captured | standing | pages 51, 100 |
| Burns | adult | 2.5% gel | NEB | not captured | standing | pages 51, 100 |
| Burns | peds | 2.5% gel | TOP | not captured | standing | pages 51, 100 |
| Burns | peds | 2.5% gel | NEB | not captured | standing | pages 51, 100 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | not captured | not captured | standing | pages 35, 91 |
| Hypoglycemia | peds | 0.5 g/kg | not captured | not captured | standing | pages 35, 91 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | adult | 2 mg | IV/IO | not captured | standing | page 7 |
| Seizure | adult | 4–20 mg | not captured | not captured | standing | pages 7, 92 |
| Seizure | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 7 |
| Seizure | peds | 0.5 mg/kg | not captured | not captured | standing | pages 7, 92 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1 mg/kg (max 50 mg) | PO | not captured | standing | pages 14, 82 |
| Allergic reaction | adult | 1 mg/kg (max 50 mg) | IM | not captured | standing | pages 14, 82 |
| Allergic reaction | adult | 1 mg/kg (max 50 mg) | IV | not captured | standing | pages 14, 82 |
| Allergic reaction | adult | 50 mg | IV | not captured | standing | pages 14, 82 |
| Allergic reaction | adult | 50 mg | IM | not captured | standing | pages 14, 82 |
| Allergic reaction | adult | 50 mg | PO | not captured | standing | pages 14, 82 |
| Allergic reaction | peds | 1 mg/kg (max 50 mg) | PO | not captured | standing | pages 14, 82 |
| Allergic reaction | peds | 1 mg/kg (max 50 mg) | IM | not captured | standing | pages 14, 82 |
| Allergic reaction | peds | 1 mg/kg (max 50 mg) | IV | not captured | standing | pages 14, 82 |
| Allergic reaction | peds | 1 mg/kg (max 50 mg) | IV | not captured | standing | pages 14, 82 |
| Allergic reaction | peds | 1 mg/kg (max 50 mg) | IM | not captured | standing | pages 14, 82 |
| Allergic reaction | peds | 1 mg/kg (max 50 mg) | PO | not captured | standing | pages 14, 82 |
| Anaphylaxis | adult | 50 mg | IV/IO | not captured | standing | pages 14, 82 |
| Anaphylaxis | adult | 50 mg | IM | not captured | standing | pages 14, 82 |
| Anaphylaxis | peds | 1 mg/kg (max 50 mg) | IV/IO | not captured | standing | pages 14, 82 |
| Anaphylaxis | peds | 1 mg/kg (max 50 mg) | IM | not captured | standing | pages 14, 82 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2–20 mcg/kg | IO | not captured | standing | page 101 |
| Bradycardia | adult | 2–20 mcg/kg | IO | not captured | standing | page 101 |
| Cardiogenic shock | adult | 2–20 mcg/kg | IO | not captured | standing | page 101 |
| Hypotension / shock | adult | 2–20 mcg/kg | IO | not captured | standing | page 101 |
| Sepsis | adult | 2–20 mcg/kg | IO | not captured | standing | page 101 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 14, 82, 102 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | pages 14, 82, 102 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | pages 15, 83 |
| Asthma / bronchospasm | peds | 0.15 mg | IM | not captured | standing | pages 15, 83 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 85, 102 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 23, 72, 102 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 23, 72, 102 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 7, 76, 103 |
| Severe pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 7, 76, 103 |
| RSI induction | adult | Standard dose | IV | not captured | standing | page 13 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV/IO/IM/IN | not captured | standing | pages 29, 89, 103 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.5 mg | IV/IO/IM/IN | not captured | standing | pages 29, 89, 103 |
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | pages 91, 103 |
| Hypoglycemia | peds | 0.5 mg | IM/IN | not captured | standing | pages 91, 103 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | not captured | not captured | standing | page 31 |
| Cyanide poisoning | peds | 70 mg/kg | not captured | not captured | standing | page 31 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | not captured | not captured | standing | pages 14, 15, 82, 83 |
| Asthma / bronchospasm | peds | 0.5 mg | not captured | not captured | standing | pages 14, 15, 82, 83 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg/kg | IV/IM/IN | not captured | standing | pages 29, 38, 89, 90, 104 |
| Agitation | peds | 2 mg/kg | IV/IM/IN | not captured | standing | pages 29, 38, 89, 90, 104 |
| Severe pain | adult | 0.25–0.3 mg/kg | IV/IM/IN | not captured | standing | pages 7, 76, 104 |
| Severe pain | peds | 0.25–0.3 mg/kg | IV/IM/IN | not captured | standing | pages 7, 76, 104 |
| RSI induction | adult | 2 mg/kg | IV/IM/IN | not captured | standing | pages 13, 104 |
| RSI induction | peds | 2 mg/kg | IV/IM/IN | not captured | standing | pages 13, 104 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | pages 26, 104 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | pages 26, 104 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV | not captured | standing | pages 26, 104 |
| Mild to moderate pain | peds | 1 mg/kg | IM | not captured | standing | pages 26, 104 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg (max 50 mg) | IO | not captured | standing | pages 6, 105 |
| Other | peds | 0.5 mg/kg (max 40 mg) | IO | not captured | standing | pages 6, 105 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | pages 15, 83 |
| Asthma / bronchospasm | peds | 25 mg/kg | IV/IO | not captured | standing | pages 15, 83 |
| Eclampsia / pre-eclampsia | adult | 2 g | IV | not captured | standing | page 73 |
| Eclampsia / pre-eclampsia | peds | 2 g | IV | not captured | standing | page 73 |
| VF / pulseless VT | adult | 2 g | IV | not captured | standing | pages 21, 87 |
| VF / pulseless VT | peds | 25 mg/kg | IV | not captured | standing | pages 21, 87 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IM/IN | not captured | standing | pages 27, 29, 38, 89 |
| Agitation | peds | 0.1 mg/kg | IV/IM/IN | not captured | standing | pages 27, 29, 38, 89 |
| Procedural sedation | adult | 2–5 mg | IV/IM/IN | not captured | standing | pages 18, 20, 21, 24, 38, 58, 86, 87 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IM/IN | not captured | standing | pages 18, 20, 21, 24, 38, 58, 86, 87 |
| Seizure | adult | 2 mg | IV/IO/IM/IN | not captured | standing | pages 27, 29, 36, 42, 79, 89, 90, 92 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 27, 29, 36, 42, 79, 89, 90, 92 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 10 mg | IM | not captured | standing | pages 7, 106 |
| Severe pain | adult | 2 mg | IV/IO | not captured | standing | pages 7, 106 |
| Severe pain | peds | 0.1 mg/kg (max 2 mg) | IV/IO | not captured | standing | pages 7, 106 |
| Severe pain | peds | 10 mg | IM | not captured | standing | pages 7, 106 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 1 mg | IV/IO/IM/IN | not captured | standing | pages 23, 28, 29, 30, 81, 88, 89, 90 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 23, 28, 29, 30, 81, 88, 89, 90 |
Nerve Agent Antidote Kit
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 1 dose | IM | not captured | standing | page 62 |
| Nerve agent exposure | adult | 1 dose | IM | not captured | standing | page 62 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 18, 106 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | pages 24, 106 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | peds | 0.1 mcg/kg | IO | not captured | standing | pages 7, 23, 43, 58, 93, 107 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | PO | not captured | standing | pages 6, 76 |
| Nausea / vomiting | adult | 4 mg | IV | not captured | standing | pages 6, 76 |
| Nausea / vomiting | peds | 0.15 mg/kg | PO | not captured | standing | pages 6, 76 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV | not captured | standing | pages 6, 76 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | pages 35, 91 |
| Hypoglycemia | peds | 0.3 g/kg | PO | not captured | standing | pages 35, 91 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV/IO | not captured | standing | page 23 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | page 23 |
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | pages 26, 56 |
| Hyperkalemia | peds | 50 mEq | IV/IO | not captured | standing | pages 26, 56 |
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | pages 29, 89 |
| Tricyclic overdose | peds | 1 mEq/kg | IV | not captured | standing | pages 29, 89 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5% 1 gtt | TOP | not captured | standing | pages 53, 108 |
| Other | peds | 0.5% 1 gtt | TOP | not captured | standing | pages 53, 108 |
| Mild to moderate pain | adult | 0.5% 1 gtt | TOP | not captured | standing | pages 53, 108 |
| Mild to moderate pain | peds | 0.5% 1 gtt | TOP | not captured | standing | pages 53, 108 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | not captured | not captured | standing | pages 48, 108 |
Verapamil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 5 mg | IV | not captured | standing | page 20 |